MedTrace Logo

Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation

NCT04969978 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9133

Last updated 2026-01-28

No results posted yet for this study

Summary

This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, tobacco cessation assistance and self-reported quit rates among patients in community health centers. It also examines the cost-effectiveness of Quitline eReferrals both with and without enhanced academic detailing. If this implementation strategy is effective, this strategy could be used to increase tobacco cessation treatment through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged patients who use tobacco.

Conditions

  • Tobacco-Related Carcinoma
  • Smoking &Amp; Tobacco Cessation

Interventions

BEHAVIORAL

Enhanced Academic Detailing

* Group training of clinic staff prior to activation of the eReferral system and 12 months post-activation * Follow-up booster sessions * Monthly performance audit and feedback

OTHER

Informational Intervention

Receive overview of Quitline services and use of Quitline eReferral via online materials

Sponsors & Collaborators

  • Kaiser Permanente

    collaborator OTHER

  • OCHIN, Inc.

    collaborator OTHER

  • Oregon Health and Science University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Steffani Bailey · OHSU Department of Family Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2025-08-22
Completion
2026-02-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969978 on ClinicalTrials.gov